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Introduction - Polypharmacy, and the associated adverse drug events such as non-adherence 
to prescriptions, is a common problem for elderly people living with multiple 
comorbidities.  Deprescribing, i.e. the gradual withdrawal from medications with supervision 
by a healthcare professional, is regarded as a means of reducing adverse effects of multiple 
medications, including non-adherence. This systematic review examined the evidence for 
deprescribing as an effective strategy for improving medication adherence amongst older, 
community dwelling adults. 
Methods – Eight scientific databases were searched for quantitative and qualitative studies 
evaluating the effect of deprescribing or medication review interventions on medication 
adherence measures in community dwelling older adults with polypharmacy, in accordance 
with the PRISMA reporting statement.  Prospero number CRD42017075315 
Results – A total of 21 original studies involving  5840 patients met the eligibility criteria 
and underwent quality appraisal and data extraction processes.  Deprescribing and adherence 
(as a secondary outcome) was identified in randomised controlled trials, observational and 
cohort studies in 12 countries between 1996-2017.  There was a large variation in assessment 
of adherence and follow-up period.  Intervention type varied considerably, but were most 
commonly delivered by pharmacists (16/21 studies). Overall 13 of the 21 studies reported 
improved medication adherence after deprescribing or medication review interventions, 
however only 4 study interventions actually resulted in statistically significant reductions in 
medication burden. Of these, all resulted in improved adherence rates.  
Conclusions - Improved adherence may result from medicines review procedures in 
community dwelling elderly people but may not be as a result of an overall reduction in 
medications taken.  The lack of evidence and the inconsistency of data suggest the need for 
further consensus building in deprescribing practice, focusing on the efficacy of medicines 
management interventions on individual and population health outcomes.  words 283 
 
